Role of direct estrogen receptor signaling in wear particle-induced osteolysis

Biomaterials

Volumn 34, Issue 3, 2013, Pages 641-650

  Nich, Christophe ^a,b,c   Rao, Allison J ^a   Valladares, Roberto D ^a   Li, Chenguang ^a   Christman, Jane E ^a   Antonios, Joseph K ^a   Yao, Zhenyu ^a   Zwingenberger, Stefan ^a,d   Petite, Hervé ^b   Hamadouche, Moussa ^b   Goodman, Stuart B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Paris university   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Estrogen receptor; Macrophages; Osteolysis; Polyethylene; Wear debris

Indexed keywords

BONE RESORPTION; CALVARIAL MODEL; DOWN-REGULATION; ESTROGEN RECEPTOR; HISTOMORPHOMETRY; IN-VITRO; MACROPHAGE ACTIVATION; MICRO CT; MRNA EXPRESSION; MURINE MACROPHAGES; OSTEOLYSIS; PRE-TREATMENT; RAW CELLS; THERAPEUTIC TARGETS; WEAR DEBRIS; WEAR PARTICLES; WILD TYPES;

COMPUTERIZED TOMOGRAPHY; DEBRIS; MACROPHAGES; MAMMALS; THERMOPLASTICS;

POLYETHYLENES;

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; MESSENGER RNA; POLY(METHYL METHACRYLATE); TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALVARIA; CELL LINE; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; GENE INACTIVATION; MACROPHAGE; MECHANICAL STRESS; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; BONE AND BONES; CELL LINE; CELLS, CULTURED; CYTOKINES; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE DELETION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOLYSIS; POLYETHYLENE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; MUS;

EID: 84868475443     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.10.030     Document Type: Article

References (56)

1. Harris W.H. The problem is osteolysis. Clin Orthop Relat Res 1995, 46-53.
2. Ingham E., Fisher J. The role of macrophages in osteolysis of total joint replacement. Biomaterials 2005, 26:1271-1286.
3. Jacobs J.J., Roebuck K.A., Archibeck M., Hallab N.J., Glant T.T. Osteolysis: basic science. Clin Orthop Relat Res 2001, 71-77.
4. Kobayashi S., Takaoka K., Saito N., Hisa K. Factors affecting aseptic failure of fixation after primary Charnley total hip arthroplasty. Multivariate survival analysis. J Bone Joint Surg Am 1997, 79:1618-1627.
5. Dowd J.E., Sychterz C.J., Young A.M., Engh C.A. Characterization of long-term femoral-head-penetration rates. Association with and prediction of osteolysis. J Bone Joint Surg Am 2000, 82-A:1102-1107.
6. Gallo J., Havranek V., Zapletalova J., Lostak J. Male gender, Charnley class C, and severity of bone defects predict the risk for aseptic loosening in the cup of ABG I hip arthroplasty. BMC Musculoskelet Disord 2010, 11:243.
7. Gallo J., Mrazek F., Petrek M. Variation in cytokine genes can contribute to severity of acetabular osteolysis and risk for revision in patients with ABG 1 total hip arthroplasty: a genetic association study. BMC Med Genet 2009, 10:109.
8. Zhang C., Tang T., Ren W., Zhang X., Dai K. Influence of mouse genetic background on wear particle-induced in vivo inflammatory osteolysis. Inflamm Res 2008, 57:211-215.
9. von Knoch M., Jewison D.E., Sibonga J.D., Turner R.T., Morrey B.F., Loer F., et al. Decrease in particle-induced osteolysis in obese (ob/ob) mice. Biomaterials 2004, 25:4675-4681.
10. Nich C., Marchadier A., Sedel L., Petite H., Vidal C., Hamadouche M. Decrease in particle-induced osteolysis in ovariectomized mice. J Orthop Res 2010, 28:178-183.
11. Nich C., Langlois J., Marchadier A., Vidal C., Cohen-Solal M., Petite H., et al. Oestrogen deficiency modulates particle-induced osteolysis. Arthritis Res Ther 2011, 13:R100.
12. Couse J.F., Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr Rev 1999, 20:358-417.
13. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., et al. The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839.
14. Krege J.H., Hodgin J.B., Couse J.F., Enmark E., Warner M., Mahler J.F., et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A 1998, 95:15677-15682.
15. Kato S., Tora L., Yamauchi J., Masushige S., Bellard M., Chambon P. A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5'-TGACC-3' motifs acting synergistically. Cell 1992, 68:731-742.
16. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995, 270:1491-1494.
17. Carroll J.S., Liu X.S., Brodsky A.S., Li W., Meyer C.A., Szary A.J., et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122:33-43.
18. Carroll J.S., Meyer C.A., Song J., Li W., Geistlinger T.R., Eeckhoute J., et al. Genome-wide analysis of estrogen receptor binding sites. Nat Genet 2006, 38:1289-1297.
19. Imai Y., Kondoh S., Kouzmenko A., Kato S. Minireview: osteoprotective action of estrogens is mediated by osteoclastic estrogen receptor. Mol Endocrinol 2010, 24:877-885.
20. Calippe B., Douin-Echinard V., Delpy L., Laffargue M., Lelu K., Krust A., et al. 17 β-estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor signaling in macrophages in vivo. J Immunol 2010, 185:1169-1176.
21. Pearl J.I., Ma T., Irani A.R., Huang Z., Robinson W.H., Smith R.L., et al. Role of the toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles. Biomaterials 2011, 32:5535-5542.
22. Campbell P., Ma S., Yeom B., McKellop H., Schmalzried T.P., Amstutz H.C. Isolation of predominantly submicron-sized UHMWPE wear particles from periprosthetic tissues. J Biomed Mater Res 1995, 29:127-131.
23. Couse J.F., Curtis S.W., Washburn T.F., Lindzey J., Golding T.S., Lubahn D.B., et al. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol Endocrinol 1995, 9:1441-1454.
24. Dauvois S., Danielian P.S., White R., Parker M.G.M. Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci U S A 1992, 89:4037-4041.
25. James A.W., Theologis A.A., Brugmann S.A., Xu Y., Carre A.L., Leucht P., et al. Estrogen/estrogen receptor alpha signaling in mouse posterofrontal cranial suture fusion. PLoS One 2009, 4:e7120.
26. Müller R., Van Campenhout H., Van Damme B., Van Der Perre G., Dequeker J., Hildebrand T., et al. Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. Bone 1998, 23:59-66.
27. Schilling D., Thomas K., Nixdorff K., Vogel S.N., Fenton M.J. Toll-like receptor 4 and toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages. J Immunol 2002, 169:5874-5880.
28. Huang Z., Ma T., Ren P.G., Smith R.L., Goodman S.B. Effects of orthopedic polymer particles on chemotaxis of macrophages and mesenchymal stem cells. J Biomed Mater Res A 2010, 94:1264-1269.
29. Vico L., Vanacker J.M. Sex hormones and their receptors in bone homeostasis: insights from genetically modified mouse models. Osteoporos Int 2010, 21:365-372.
30. Da Silva J.A., Willoughby D.A. The influence of sex in arthritis: is cartilage an overlooked factor?. J Rheumatol 1994, 21:791-796.
31. Straub R.H. The complex role of estrogens in inflammation. Endocr Rev 2007, 28:521-574.
32. Rettew J.A., Huet Y.M., Marriott I. Estrogens augment cell surface TLR4 expression on murine macrophages and regulate sepsis susceptibility in vivo. Endocrinology 2009, 150:3877-3884.
33. Kimble R.B., Srivastava S., Ross F.P., Matayoshi A., Pacifici R.R. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem 1996, 271:28890-28897.
34. Childs L.M., Goater J.J., O'Keefe R.J., Schwarz E.M. Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res 2001, 16:338-347.
35. Zhang Y.H., Heulsmann A., Tondravi M.M., Mukherjee A., Abu-Amer Y.Y. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J Biol Chem 2001, 276:563-568.
36. Kimble R.B., Matayoshi A.B., Vannice J.L., Kung V.T., Williams C., Pacifici R. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 1995, 136:3054-3061.
37. Roggia C., Gao Y., Cenci S., Weitzmann M.N., Toraldo G., Isaia G., et al. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A 2001, 98:13960-13965.
38. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989, 145-173.
39. Rao A.J., Gibon E., Ma T., Yao Z., Smith R.L., Goodman S.B. Revision joint replacement, wear particles, and macrophage polarization. Acta Biomater 2012, 8:2815-2823.
40. Ricci M., Matucci A., Rossi O.O. IL-4 as a key factor influencing the development of allergen-specific Th2-like cells in atopic individuals. J Investig Allergol Clin Immunol 1997, 7:144-150.
41. Paul W.E. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 1991, 77:1859-1870.
42. Woerly G., Roger N., Loiseau S., Capron M. Expression of Th1 and Th2 immunoregulatory cytokines by human eosinophils. Int Arch Allergy Immunol 1999, 118:95-97.
43. Pouliot P., Turmel V., Gelinas E., Laviolette M., Bissonnette E.Y. Interleukin-4 production by human alveolar macrophages. Clin Exp Allergy 2005, 35:804-810.
44. Büttner C., Skupin A., Reimann T., Rieber E.P., Unteregger G., Geyer P., et al. Local production of interleukin-4 during radiation-induced pneumonitis and pulmonary fibrosis in rats: macrophages as a prominent source of interleukin-4. Am J Respir Cell Mol Biol 1997, 17:315-325.
45. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001, 2:675-680.
46. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 2000, 406:782-787.
47. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature 2001, 413:732-738.
48. Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., Goodlett D.R., et al. The innate immune response to bacterial flagellin is mediated by toll-like receptor 5. Nature 2001, 410:1099-1103.
49. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., et al. Cutting edge: role of toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002, 169:10-14.
50. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
51. Beutler B. Inferences, questions and possibilities in toll-like receptor signalling. Nature 2004, 430:257-263.
52. Lähdeoja T., Pajarinen J., Kouri V.-P., Sillat T., Salo J., Konttinen Y.T. Toll-like receptors and aseptic loosening of hip endoprosthesis-a potential to respond against danger signals?. J Orthop Res 2010, 28:184-190.
53. Takagi M., Tamaki Y., Hasegawa H., Takakubo Y., Konttinen L., Tiainen V.-M., et al. Toll-like receptors in the interface membrane around loosening total hip replacement implants. J Biomed Mater Res B Appl Biomater 2007, 81:1017-1026.
54. Pajarinen J., Cenni E., Savarino L., Gomez-Barrena E., Tamaki Y., Takagi M., et al. Profile of toll-like receptor-positive cells in septic and aseptic loosening of total hip arthroplasty implants. J Biomed Mater Res A 2010, 94:84-92.
55. Croxtall J.D., McKeage K. Fulvestrant: a review of its use in the management of hormone receptor-positive metastatic breast cancer in postmenopausal women. Drugs 2011, 71:363-380.
56. Kou X.-X., Wu Y.-W., Ding Y., Hao T., Bi R.-Y., Gan Y.-H., et al. 17β-estradiol aggravates temporomandibular joint inflammation through the NF-κB pathway in ovariectomized rats. Arthritis Rheum 2011, 63:1888-1897.